<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00264979</url>
  </required_header>
  <id_info>
    <org_study_id>DGS 2005/0193</org_study_id>
    <secondary_id>PHRC/04-01</secondary_id>
    <secondary_id>CIC0203/030</secondary_id>
    <nct_id>NCT00264979</nct_id>
  </id_info>
  <brief_title>Evaluation of 2 Resection Strategies of Synchronous Colorectal Cancer Metastases</brief_title>
  <acronym>METASYNC</acronym>
  <official_title>Prospective Randomized Study Comparing the Morbidity and Mortality After Liver Resection for Synchronous Colorectal Cancer Metastases When Performed Either During or 12 to 14 Weeks After the Primary Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The surgical strategy for the treatment of synchronous colorectal cancer liver metastases has
      not still been defined. The purpose of this study is to compare two treatment strategies in
      which liver resection is performed either during, or 12 to 14 weeks after the primary
      resection. Endpoints include the rate of severe complications and survival.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In France, 35 000 colorectal cancers are diagnosed each year, 15 to 25% of which with hepatic
      metastases. It is nowadays admitted that the complete resection of these hepatic metastases
      represents the only treatment that has been shown to increase survival. The aim of this study
      is to evaluate the efficacy/safety ratio of the liver surgery when performed simultaneously
      or at distance of the primitive tumour ablation. Patients are randomized to undergo liver
      surgery either during, or 12 to 14 weeks after the primary resection. The primary endpoint is
      the rate of patients with at least one severe complication within 60 days after surgery.
      Secondary endpoints evaluate long-term clinical outcomes, in particular recurrence-free
      survival.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Stop recommended following the last sequential analysis
  </why_stopped>
  <start_date>December 2005</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients with at least one postoperative severe complication within 60 days after each surgery</measure>
    <time_frame>60 days after each surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death rate during hospitalization or within 60 days after each surgery</measure>
    <time_frame>60 days after each surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate and number of severe general, digestive or hepatic complications</measure>
    <time_frame>2 years after the first surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of unachieved hepatic resection</measure>
    <time_frame>Day of the hepatic surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global survival distribution and 2 years global survival rate</measure>
    <time_frame>2 years after the first surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence-free survival distribution and 2 years recurrence-free survival rate</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Two years recurrence rate</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">105</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Hepatic Metastases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Simultaneous surgery of colorectal cancer and synchronous liver metastases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Sequential surgeries of colorectal cancer and synchronous liver metastases</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Simultaneous surgery</intervention_name>
    <description>Simultaneous surgery of colorectal cancer and synchronous liver metastases</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sequential surgery</intervention_name>
    <description>Sequential surgeries of colorectal cancer and synchronous liver metastases: the metastases surgery will be programmed 12 to 14 weeks after the primary tumour exeresis.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female adults over 18 years old

          -  At least one adenocarcinoma of colon and/or rectum, histologically proven.

          -  No local complication at the time of surgery (no occlusion, no sub-occlusion, no
             massive hemorrhage, no abscesses or local invasion)

          -  At least one hepatic metastasis which R0 resection is possible through a conventional
             simple resection

          -  Informed written consent.

        Non inclusion criteria:

          -  Heart, Respiratory or Renal failure

          -  Physical or psychological dependence

          -  Chronic liver disease

          -  Extra-hepatic metastases

        Exclusion Criteria (at time of surgery)

          -  Localized or diffuse peritoneal carcinomatosis

          -  Non resectable lymph node metastases

          -  Colorectal or hepatic tumour extension towards abdominal wall and/or adjacent organ
             making liver R0 resection impossible immediately

          -  Other hepatic lesions diagnosed with ultrasound making liver R0 resection impossible
             immediately
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karim Boudjema, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jean-Luc Raoul, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Eugène Marquis - CRLCC Rennes</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Bellissant, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Chirurgie générale viscérale et digestive - Hôpital Nord</name>
      <address>
        <city>Amiens</city>
        <zip>80080</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie viscérale, digestive et cancérologie - Hôpital Jean Mingoz</name>
      <address>
        <city>Besancon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgie digestive, thoracique et cancérologie</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Département de Chirurgie - CRLCC Léon Bérard</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Chirurgicale A - Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Chirurgicale I - Hôpital Nord</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Chirurgie et Réanimation Digestives - Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <zip>75570</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie hépato-biliaire et Transplantation Hépatique- Paris Saint Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie - Hôpital Jean Bernard</name>
      <address>
        <city>Poitiers</city>
        <zip>86021</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'Oncologie Digestive- CRLCC Eugène Marquis</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Département de Chirurgie Viscérale - Hôpital Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de Chirurgie Viscérale et de Transplantation - CHU de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Chirurgie Viscérale Digestive - CH Chubert</name>
      <address>
        <city>Vannes</city>
        <zip>70555</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hépato-biliaire - Hôpital Paul Brousse</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Martin R, Paty P, Fong Y, Grace A, Cohen A, DeMatteo R, Jarnagin W, Blumgart L. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg. 2003 Aug;197(2):233-41; discussion 241-2.</citation>
    <PMID>12892803</PMID>
  </reference>
  <reference>
    <citation>Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg. 2003 Aug;90(8):956-62.</citation>
    <PMID>12905548</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2005</study_first_submitted>
  <study_first_submitted_qc>December 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2005</study_first_posted>
  <last_update_submitted>August 21, 2017</last_update_submitted>
  <last_update_submitted_qc>August 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal cancer</keyword>
  <keyword>Sequential or simultaneous surgery</keyword>
  <keyword>Synchronous hepatic metastases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
    <mesh_term>Neoplasms, Second Primary</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

